Clinical Study Centers, LLC Report issue

For profit Phase 2
Founded: Little Rock AR United States (1998)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2004
NCT00557011
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Clinical Study Centers, LLC

Active Ingredients

Drugs in Phase 2 Trials (2)

amphetamine (Adderall) (1 trial)

lisdexamfetamine (vyvanse) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 2)

Hyperkinesis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2